SALT LAKE CITY–(HSMN NewsFeed)–BSD Medical Corporation (NASDAQ:BSDM ) reports initiation of a randomized, multicenter Phase III medical study using the BSD-2000 Hyperthermia System in combination with chemotherapy for the treatment of pancreatic cancer …
Devices, Oncology
BSD Medical, BSD-2000, Hyperthermia, pancreatic cancer

If you are a sales professional or want to become one, or if you are looking for a new sales job, you will face one of the toughest interview processes of any job seeker.
0 Comments on “BSD Clinical Reports Initiation of a Phase III Study on Pancreatic Cancer Using the BSD-2000 Hyperthermia System in Combination with Chemotherapy”
Leave a Comment